Oragenics
OGEN
18 hedge funds and large institutions have $169K invested in Oragenics in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
13% more funds holding
Funds holding: 16 → 18 (+2)
5% more capital invested
Capital invested by funds: $161K → $169K (+$8.73K)
2.22% more ownership
Funds ownership: 2.97% → 5.18% (+2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$55.2K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$36.6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.71K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.02K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AF
Allworth Financial
Folsom,
California
|
-$438 |
| 2 |
EWM
Evermay Wealth Management
Arlington,
Virginia
|
-$2 |
OGEN Hedge Fund Activity: Q4 2025 in Review
18 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2025, worth a combined $169K — up 5.4% from $161K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OGEN positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was DRW Securities, adding an estimated $55.2K. The largest seller was Allworth Financial, exiting entirely with an estimated $438 sold.
- 18 institutional investors held Oragenics (OGEN) as of Q4 2025, up from 16 in Q3 2025.
- Funds reported $169K of Oragenics stock for Q4 2025, up 5.4% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q4 2025 and 2 closed out, a net change of +2 holders.
- The largest Oragenics buyer in Q4 2025 was DRW Securities, an estimated $55.2K added.
- The largest Oragenics seller in Q4 2025 was Allworth Financial, an estimated $438 sold.
Based on aggregated 13F filings for Q4 2025.